RAPT Therapeutics, Inc. (RAPT) Leases (2022 - 2024)
RAPT Therapeutics (RAPT) has disclosed Leases for 3 consecutive years, with $3.8 million as the latest value for Q3 2024.
- Quarterly Leases fell 32.56% to $3.8 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Sep 2024, down 32.56% year-over-year, with the annual reading at $5.2 million for FY2023, 24.67% down from the prior year.
- Leases hit $3.8 million in Q3 2024 for RAPT Therapeutics, down from $4.3 million in the prior quarter.
- In the past five years, Leases ranged from a high of $6.9 million in Q4 2022 to a low of $3.8 million in Q3 2024.
- Historically, Leases has averaged $5.6 million across 3 years, with a median of $5.8 million in 2022.
- Biggest five-year swings in Leases: increased 3.23% in 2023 and later plummeted 32.56% in 2024.
- Year by year, Leases stood at $6.9 million in 2022, then fell by 24.67% to $5.2 million in 2023, then fell by 26.84% to $3.8 million in 2024.
- Business Quant data shows Leases for RAPT at $3.8 million in Q3 2024, $4.3 million in Q2 2024, and $4.8 million in Q1 2024.